![Daniel Welch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Welch
Presidente presso
PROTHENA CORPORATION PLC
Patrimonio netto: 3 M $ in data 31/05/2026
Profilo
Daniel G. Welch è un uomo d'affari che è stato a capo di 8 diverse aziende e ricopre la posizione di Presidente non esecutivo per Ultragenyx Pharmaceutical, Inc., Presidente esecutivo per InCarda Therapeutics, Inc. e Presidente per Nuvation Bio, Inc. (una filiale di Nuvation Bio, Inc.). È anche nel consiglio di amministrazione di Seagen Inc., Intercept Pharmaceuticals, Inc. e Levo Therapeutics, Inc. (ex presidente esecutivo). In passato il sig. Welch ha ricoperto la posizione di partner esecutivo presso Sofinnova Investments, Inc., presidente e amministratore delegato di Triangle Pharmaceuticals, Inc., presidente, presidente e amministratore delegato di InterMune, Inc., presidente di AveXis, Inc., presidente della divisione biofarmaceutica di Elan Corp. Plc, direttore di Adria Laboratories, vicepresidente del marketing mondiale della Sterling Winthrop, Inc. e direttore operativo e vicepresidente esecutivo della Sanofi-Synthelabo, Inc. Daniel G. Welch ha conseguito una laurea presso l'Università di Miami e un MBA presso l'Università del North Carolina a Charlotte.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/06/2026 | 123.508 ( 0,09% ) | 2 M $ | 31/05/2026 | |
| 14/05/2026 | 40.441 ( 0,04% ) | 968 158 $ | 31/05/2026 | |
PROTHENA CORP. PLC -.--% | 15/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Daniel Welch
| Società | Posizione | Inizio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Presidente | 18/06/2015 |
| STRUCTURE THERAPEUTICS INC. | Presidente | 19/01/2022 |
| PROTHENA CORPORATION PLC | Presidente | 14/05/2024 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Presidente | - |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Presidente | 07/03/2019 |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Presidente | 01/08/2018 |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Presidente | 30/06/2026 |
Precedenti posizioni note di Daniel Welch
| Società | Posizione | Fine |
|---|---|---|
| NUVATION BIO INC. | Presidente | 03/09/2024 |
| SEAGEN INC. | Direttore/Membro del Consiglio | 14/12/2023 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Daniel Welch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
24
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 24 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antiviral drug candidates | Commercial Services |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Sterling Winthrop, Inc.
 Sterling Winthrop, Inc. Electronics/AppliancesConsumer Durables Cameras; duplicating machines | Consumer Durables |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Sanofi-Synthelabo, Inc. | Health Technology |
Adria Laboratories | |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Health Technology |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Sofinnova Ventures | |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
